Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Total Current Liabilities (2023 - 2025)

Upstream Bio has reported Total Current Liabilities over the past 3 years, most recently at $13.5 million for Q4 2025.

  • Quarterly results put Total Current Liabilities at $13.5 million for Q4 2025, up 25.29% from a year ago — trailing twelve months through Dec 2025 was $13.5 million (up 25.29% YoY), and the annual figure for FY2025 was $13.5 million, up 25.29%.
  • Total Current Liabilities for Q4 2025 was $13.5 million at Upstream Bio, up from $11.9 million in the prior quarter.
  • Over the last five years, Total Current Liabilities for UPB hit a ceiling of $13.5 million in Q4 2025 and a floor of $6.5 million in Q4 2023.
  • Median Total Current Liabilities over the past 3 years was $10.9 million (2024), compared with a mean of $10.6 million.
  • Biggest five-year swings in Total Current Liabilities: skyrocketed 64.8% in 2024 and later rose 9.51% in 2025.
  • Upstream Bio's Total Current Liabilities stood at $6.5 million in 2023, then skyrocketed by 64.8% to $10.7 million in 2024, then increased by 25.29% to $13.5 million in 2025.
  • The last three reported values for Total Current Liabilities were $13.5 million (Q4 2025), $11.9 million (Q3 2025), and $10.9 million (Q2 2025) per Business Quant data.